Page 79 - Amgen News Today

The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

Smead Capital Management Inc. cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 7.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,029,768 shares of the medical research company’s stock after selling 80,556 shares during the quarter. Amgen comprises approximately 5.3% […]

The novel agent has shown no immunogenicity issues thus far and might be a promising new PCSK9 inhibitor option.

Genesee Capital Advisors LLC bought a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,525 shares of the medical research company’s stock, valued at approximately $1,015,000. Other institutional investors […]

Amgen (NASDAQ:AMGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Truist Financial in a report released on Friday, Benzinga reports. They currently have a $320.00 price objective on the medical research company’s stock. Truist Financial’s price target would suggest a potential upside of 19.33% from the company’s previous close. […]

Roger Samuelsson is a new billionaire thanks to soaring demand from big pharma firms like Novo Nordisk for his company SHL Medical’s autoinjectors.

Signature Estate & Investment Advisors LLC increased its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,988 shares of the medical research company’s stock after acquiring an additional 226 shares during the […]

Signature Estate & Investment Advisors LLC grew its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 8.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,988 shares of the medical research company’s stock after buying an additional 226 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in […]

Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY[®]▼ can help to close the treatment gap in osteoporosi The first cohort...